Trial · NCT07910734
Supplemental Blood Flow Restriction Training to Improve the Upper Extremity in Chronic Stroke
NCT07910734, Not applicable, Completed, Saint Joseph's University, Philadelphia
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Supplemental Blood Flow Restriction Training to Improve the Upper Extremity in Chronic Stroke. Trials, record NCT07910734. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910734
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Supplemental Blood Flow Restriction Training to Improve the Upper Extremity in Chronic Stroke
- NCT number
- NCT07910734
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 16 participants, actual
- Lead sponsor
- Saint Joseph's University, Philadelphia
- Conditions
- Cerebro-vascular Accident, Exercise, Blood Flow Restriction (BFR) Training Effects
- Interventions
- BFR
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Wearable Accelerometry | Subjects wear the wrist accelerometers up to 3 days from enrollment prior to training, for a 3-day period, and up to 3 days post-training for a 3-day period | The parameters extracted from the accelerometry data consist of upper limb use, bilateral magnitude, use ratio, and magnitude ratio. The upper limb use denotes the duration (in hours) they used their involved arm. Bilateral magnitude measures the intensity of movement in bilateral UEs on a scale of 0-300, indicating minimal to maximal intensity. Use a ratio to compare the usage of the involved vs. involved UE in terms of overall movement throughout the designated time period. Magnitude ratio compares both intensity and amount of use between the involved and uninvolved UE, using a scale of -7 to 7. A leftward shift, or grade below 0, signifies more use of the uninvolved UE. A rightward shift, or grade above 0, indicates increased use of the involved UE. |
| Primary | Upper Extremity Fugl-Meyer (UE FMA) for upper extremity impairment measure | Data collected up to 3 days prior to training and then up to 3 days post-training | A measure of impairment measuring changes in upper extremity movement and motor control (ranging from 0 to 66, with a higher score a better outcome) |
| Primary | Wolf Motor Function Test (WMFT) for upper extremity function | Data collected up to 3 days prior to training initiation and then up to 3 days post training completion | The Wolf Motor Function Test is an activity measure that assesses the UE motor function through the use of timed and functional tasks performed at each joint. Several tasks are performed utilizing the parameters of as many repetitions as possible or within 120 seconds. Tasks included in the WMFT are performed from the most proximal to the most distal joints of the bilateral upper extremity (BUE), revealing motor deficits present between the uninvolved and involved UE. Lower time equals a better outcome, but the movement quality is scored 0-5, with 5 being a better outcome. |
| Secondary | Stroke Impact Scale participation measure | Data collected up to 3 days prior to training initiation and then up to 3 days post training completion | The SIS is a patient-reported outcome measure and was used to quantify the patient's perception of their baseline function as well as overall strength and mobility and to identify changes in this following treatment. This outcome measure assessed the subjects' perception of their own strength, hand function, activities of daily living, mobility, communication, emotion, memory \& thinking, and participation. Each category was scored between 0 and 100, with higher scores indicating greater patient-perceived function. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07910734
GET https://conductscience.org/api/trials/v1/NCT07910734/registered